Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression
- PMID: 15897991
- DOI: 10.1086/430320
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression
Abstract
Background: Strong T cell and antibody responses to human immunodeficiency virus (HIV), low virus production, and some genetic traits have been individually associated with nonprogression of HIV infection, but the best correlate with protection against disease progression remains unknown.
Methods: We prospectively followed 66 untreated long-term nonprogressors and analyzed relationships between HIV-1-specific CD4 T helper (Th) 1 and CD8 T cell responses and HIV-1-specific antibodies, HIV-1 RNA and proviral DNA loads, host genes, and CD4 Th1 cell counts at entry into the study and 4 years later.
Results: HIV-1 p24-specific CD4 Th1 cell proliferation, interferon (IFN)- gamma production, and IFN- gamma -producing cell frequencies at entry significantly and negatively correlated with HIV-1 RNA and proviral DNA loads and were independent of CD4 Th1 cell counts and host genes. HIV-1 Gag-specific IFN- gamma -producing CD8 T cell frequencies correlated with HIV-1 proviral DNA loads but not with RNA loads. Only high frequencies of HIV-1 p24-specific CD4 Th1 cells combined with HIV-1 gp41-specific IgG2 antibodies significantly predicted persistence of high CD4 Th1 cell counts.
Conclusion: HIV-1-specific CD4 Th1 responses combined with IgG2 antibodies and IFN- gamma -producing CD4 Th1 cells are better predictors of long-term nonprogression than are virus parameters, host genes, or HIV-1-specific CD4 Th1 or CD8 T cell proliferation.
Comment in
-
Immunoglobulin G2 antibodies and HIV-infected long-term nonprogressors: what is the mechanism?J Infect Dis. 2006 Apr 1;193(7):1047; author reply 1047-8. doi: 10.1086/500837. J Infect Dis. 2006. PMID: 16518769 No abstract available.
Similar articles
-
HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.J Infect Dis. 2004 Apr 1;189(7):1199-208. doi: 10.1086/382028. Epub 2004 Mar 17. J Infect Dis. 2004. PMID: 15031788
-
Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.Clin Infect Dis. 2009 Jan 1;48(1):123-32. doi: 10.1086/595013. Clin Infect Dis. 2009. PMID: 19035778
-
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1435-46. doi: 10.1089/088922201753197105. AIDS Res Hum Retroviruses. 2001. PMID: 11679156
-
Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.J Infect Dis. 2005 Mar 15;191(6):873-80. doi: 10.1086/427828. Epub 2005 Jan 31. J Infect Dis. 2005. PMID: 15717261
-
The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?Expert Rev Mol Med. 2005 Feb 8;7(2):1-21. doi: 10.1017/S1462399405008859. Expert Rev Mol Med. 2005. PMID: 15710051 Review.
Cited by
-
Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):e90-e92. doi: 10.1097/QAI.0000000000001477. J Acquir Immune Defic Syndr. 2017. PMID: 28604502 Free PMC article.
-
Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Front Immunol. 2017 Jul 4;8:780. doi: 10.3389/fimmu.2017.00780. eCollection 2017. Front Immunol. 2017. PMID: 28725225 Free PMC article. Review.
-
Transcriptome analysis of CD4+ T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity.Virol Sin. 2023 Jun;38(3):398-408. doi: 10.1016/j.virs.2023.03.001. Epub 2023 Mar 11. Virol Sin. 2023. PMID: 36907331 Free PMC article.
-
CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.PLoS Pathog. 2011 May;7(5):e1002049. doi: 10.1371/journal.ppat.1002049. Epub 2011 May 12. PLoS Pathog. 2011. PMID: 21589903 Free PMC article.
-
A Plausible Framework Reveals Potential Similarities in the Regulation of Immunity against Some Cancers and Some Infectious Agents: Implications for Prevention and Treatment.Cancers (Basel). 2024 Apr 7;16(7):1431. doi: 10.3390/cancers16071431. Cancers (Basel). 2024. PMID: 38611110 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials